BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26011634)

  • 1. Onset of hepatocarcinogen-specific cell proliferation and cell cycle aberration during the early stage of repeated hepatocarcinogen administration in rats.
    Kimura M; Abe H; Mizukami S; Tanaka T; Itahashi M; Onda N; Yoshida T; Shibutani M
    J Appl Toxicol; 2016 Feb; 36(2):223-37. PubMed ID: 26011634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of spindle checkpoint function ahead of facilitation of cell proliferation by repeated administration of hepatocarcinogens in rats.
    Kimura M; Mizukami S; Watanabe Y; Hasegawa-Baba Y; Onda N; Yoshida T; Shibutani M
    J Toxicol Sci; 2015 Dec; 40(6):855-71. PubMed ID: 26558467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant cell cycle regulation in rat liver cells induced by post-initiation treatment with hepatocarcinogens/hepatocarcinogenic tumor promoters.
    Kimura M; Mizukami S; Watanabe Y; Onda N; Yoshida T; Shibutani M
    Exp Toxicol Pathol; 2016 Aug; 68(7):399-408. PubMed ID: 27402199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of cell cycle proteins in the livers of rats treated with hepatocarcinogens for 28 days.
    Yafune A; Taniai E; Morita R; Nakane F; Suzuki K; Mitsumori K; Shibutani M
    Arch Toxicol; 2013 Jun; 87(6):1141-53. PubMed ID: 23411599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of spindle checkpoint function in rats following 28 days of repeated administration of renal carcinogens.
    Kimura M; Mizukami S; Watanabe Y; Hasegawa-Baba Y; Onda N; Yoshida T; Shibutani M
    J Toxicol Sci; 2016 Feb; 41(1):91-104. PubMed ID: 26763396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant activation of ubiquitin D at G2 phase and apoptosis by carcinogens that evoke cell proliferation after 28-day administration in rats.
    Taniai E; Yafune A; Hayashi H; Itahashi M; Hara-Kudo Y; Suzuki K; Mitsumori K; Shibutani M
    J Toxicol Sci; 2012; 37(6):1093-111. PubMed ID: 23208426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruptive cell cycle regulation involving epigenetic downregulation of Cdkn2a (p16(Ink4a)) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats.
    Tsuchiya T; Wang L; Yafune A; Kimura M; Ohishi T; Suzuki K; Mitsumori K; Shibutani M
    Toxicology; 2012 Sep; 299(2-3):146-54. PubMed ID: 22659510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
    Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant activation of M phase proteins by cell proliferation-evoking carcinogens after 28-day administration in rats.
    Yafune A; Taniai E; Morita R; Hayashi H; Suzuki K; Mitsumori K; Shibutani M
    Toxicol Lett; 2013 Jun; 219(3):203-10. PubMed ID: 23535288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuations in cell proliferation, apoptosis, and cell cycle regulation at the early stage of tumor promotion in rat two-stage carcinogenesis models.
    Taniai E; Yafune A; Kimura M; Morita R; Nakane F; Suzuki K; Mitsumori K; Shibutani M
    J Toxicol Sci; 2012; 37(6):1113-26. PubMed ID: 23208427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of UBE2E2 in rat liver cells after hepatocarcinogen treatment facilitates cell proliferation and slowing down of DNA damage response in GST-P-expressing preneoplastic lesions.
    Mizukami S; Watanabe Y; Saegusa Y; Nakajima K; Ito Y; Masubuchi Y; Yoshida T; Shibutani M
    Toxicol Appl Pharmacol; 2017 Nov; 334():207-216. PubMed ID: 28899750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models.
    Yafune A; Taniai E; Morita R; Akane H; Kimura M; Mitsumori K; Shibutani M
    Exp Toxicol Pathol; 2014 Jan; 66(1):1-11. PubMed ID: 23890812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular distribution of cell cycle-related molecules in the renal tubules of rats treated with renal carcinogens for 28 days: relationship between cell cycle aberration and carcinogenesis.
    Taniai E; Hayashi H; Yafune A; Watanabe M; Akane H; Suzuki K; Mitsumori K; Shibutani M
    Arch Toxicol; 2012 Sep; 86(9):1453-64. PubMed ID: 22411272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of TMEM70 in Rat Liver Cells After Hepatocarcinogen Treatment Related to the Warburg Effect in Hepatocarcinogenesis Producing GST-P-Expressing Proliferative Lesions.
    Mizukami S; Watanabe Y; Nakajima K; Hasegawa-Baba Y; Jin M; Yoshida T; Shibutani M
    Toxicol Sci; 2017 Sep; 159(1):211-223. PubMed ID: 28903497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of low-density lipoprotein receptor class A domain-containing protein 4 (Ldlrad4) in the liver of rats treated with nongenotoxic hepatocarcinogen to induce transforming growth factor β signaling promoting cell proliferation and suppressing apoptosis in early hepatocarcinogenesis.
    Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Okano H; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
    J Appl Toxicol; 2020 Nov; 40(11):1467-1479. PubMed ID: 32596862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression profiling between genotoxic and non-genotoxic hepatocarcinogens in young rat liver determined by quantitative real-time PCR and principal component analysis.
    Suenaga K; Takasawa H; Watanabe T; Wako Y; Suzuki T; Hamada S; Furihata C
    Mutat Res; 2013 Feb; 751(1):73-83. PubMed ID: 23183053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ochratoxin A induces karyomegaly and cell cycle aberrations in renal tubular cells without relation to induction of oxidative stress responses in rats.
    Taniai E; Yafune A; Nakajima M; Hayashi SM; Nakane F; Itahashi M; Shibutani M
    Toxicol Lett; 2014 Jan; 224(1):64-72. PubMed ID: 24120684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of G1 cell cycle regulators in rat liver upon repeated exposure to thioacetamide.
    Kim KT; Han SY; Jeong JS
    Korean J Hepatol; 2007 Mar; 13(1):81-90. PubMed ID: 17380078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
    Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.